Suppr超能文献

螯合剂对大鼠硫代苹果酸金钠分布、排泄及肾毒性的比较效应

Comparative effects of chelating agents on distribution, excretion, and renal toxicity of gold sodium thiomalate in rats.

作者信息

Takahashi Y, Funakoshi T, Shimada H, Kojima S

机构信息

NTT Kyushu General Hospital, Kumamoto, Japan.

出版信息

Toxicology. 1994 May 31;90(1-2):39-51. doi: 10.1016/0300-483x(94)90203-8.

Abstract

The effects of various chelating agents, such as (2S)-1-(3-mercaptopropionyl)-L-proline (captopril), N-(2-mercaptopropionyl)-glycine (tiopronin), L-cysteine (L-Cys), D-cysteine (D-Cys), N-acetyl-L-cysteine (L-NAC), N-benzyl-D-glucamine dithiocarbamate (BGD), and ethylenediaminetetraacetate (EDTA), on the distribution, excretion, and renal toxicity of gold sodium thiomalate (AuTM) in rats were investigated. Rats were intraperitoneally injected with the chelating agents (1.2 mmol/kg each) immediately after intravenous injection of AuTM (0.026 mmol/kg). Treatment with captopril or tiopronin significantly prevented increases in the urinary excretion of protein, aspartate aminotransferase (AST), and glucose and the blood urea nitrogen (BUN) level after AuTM injection. L-NAC and D-Cys significantly prevented increases in the urinary excretion of protein, AST, and glucose after AuTM injection, but did not reduce to control levels. Treatment with BGD, EDTA, or L-Cys did not prevent AuTM-induced increases in the urinary excretion of protein, AST, and glucose and BUN level. Tiopronin significantly increased the urinary excretion of gold. Captopril slightly promoted both the urinary and fecal excretion of gold, resulting in the significant increase in the total excretion of the metal. Tiopronin and captopril significantly decreased the gold concentration in the kidney and liver. L-Cys, D-Cys, L-NAC, BGD, and EDTA had no significant effect on the excretion or distribution of gold at 7 days after AuTM injection. These results indicate that tiopronin and captopril can ameliorate the renal toxicity induced by AuTM. In addition, the comparative effects of 2,3-dimercaptopropane sulfonate (DMPS), N-(2-mercapto-2-methylpropanoyl)-L-cysteine (bucillamine), captopril, and tiopronin at various dose levels (1.2, 0.4 or 0.2 mmol/kg) on the distribution and renal toxicity of gold were studied. DMPS was effective in removing gold from the kidney and in protecting against the renal toxicity after AuTM injection at the even lower dose level (0.2 mmol/kg). Bucillamine and tiopronin protected against the renal toxicity of gold at dose levels of 0.4 and 1.2 mmol/kg and captopril ameliorated the gold toxicity only at higher dose level (1.2 mmol/kg).

摘要

研究了各种螯合剂,如(2S)-1-(3-巯基丙酰基)-L-脯氨酸(卡托普利)、N-(2-巯基丙酰基)-甘氨酸(硫普罗宁)、L-半胱氨酸(L-Cys)、D-半胱氨酸(D-Cys)、N-乙酰-L-半胱氨酸(L-NAC)、N-苄基-D-葡糖胺二硫代氨基甲酸盐(BGD)和乙二胺四乙酸(EDTA)对大鼠硫代苹果酸金钠(AuTM)的分布、排泄及肾毒性的影响。大鼠静脉注射AuTM(0.026 mmol/kg)后立即腹腔注射螯合剂(各1.2 mmol/kg)。卡托普利或硫普罗宁治疗可显著预防AuTM注射后尿蛋白、天冬氨酸转氨酶(AST)、葡萄糖排泄增加及血尿素氮(BUN)水平升高。L-NAC和D-Cys可显著预防AuTM注射后尿蛋白、AST和葡萄糖排泄增加,但未降至对照水平。BGD、EDTA或L-Cys治疗不能预防AuTM诱导的尿蛋白、AST、葡萄糖排泄增加及BUN水平升高。硫普罗宁显著增加了尿金排泄。卡托普利略微促进了尿金和粪金排泄,导致金属总排泄量显著增加。硫普罗宁和卡托普利显著降低了肾脏和肝脏中的金浓度。AuTM注射后7天,L-Cys、D-Cys、L-NAC、BGD和EDTA对金的排泄或分布无显著影响。这些结果表明,硫普罗宁和卡托普利可改善AuTM诱导的肾毒性。此外,还研究了不同剂量水平(1.2、0.4或0.2 mmol/kg)的2,3-二巯基丙烷磺酸钠(DMPS)、N-(2-巯基-2-甲基丙酰基)-L-半胱氨酸(布西拉明)、卡托普利和硫普罗宁对金的分布和肾毒性的比较作用。在更低剂量水平(0.2 mmol/kg)下,DMPS在AuTM注射后能有效从肾脏中清除金并预防肾毒性。布西拉明和硫普罗宁在0.4和1.2 mmol/kg剂量水平下可预防金的肾毒性,而卡托普利仅在较高剂量水平(1.2 mmol/kg)下可改善金毒性。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验